MAL Protein Expression in Neoplastic Cells of PMBLs and Peripheral DLBLs
| PMBLs . | Peripheral DLBLs . | ||
|---|---|---|---|
| Patients . | MAL . | Patients . | MAL . |
| 1 | 0 | 13 | 0 |
| 2 | +++ | 14 | 0 |
| 3 | NI | 15 | 0 |
| 4 | NI | 16 | 0 |
| 5 | + | 17 | 0 |
| 6 | +++ | 18 | 0 |
| 7 | +++ | 19 | 0 |
| 8 | NI | 20 | 0 |
| 9 | 0 | ||
| 10 | +++ | ||
| 11 | + | ||
| 12 | +++ | ||
| PMBLs . | Peripheral DLBLs . | ||
|---|---|---|---|
| Patients . | MAL . | Patients . | MAL . |
| 1 | 0 | 13 | 0 |
| 2 | +++ | 14 | 0 |
| 3 | NI | 15 | 0 |
| 4 | NI | 16 | 0 |
| 5 | + | 17 | 0 |
| 6 | +++ | 18 | 0 |
| 7 | +++ | 19 | 0 |
| 8 | NI | 20 | 0 |
| 9 | 0 | ||
| 10 | +++ | ||
| 11 | + | ||
| 12 | +++ | ||
The number of large neoplastic cells positive with the anti-MAL antibody was scored as follows: 0, negative; +, <20%; ++, 20% to 50%; +++, >50%.
Abbreviation: NI, not interpretable (absence of internal positive control).